A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial

被引:154
作者
Vinereanu, Dragos [1 ]
Lopes, Renato D. [2 ,3 ,4 ]
Cecilia Bahit, M. [5 ,6 ]
Xavier, Denis [7 ]
Jiang, Jie [8 ]
Al-Khalidi, Hussein R. [2 ]
He, Wensheng [2 ]
Xian, Ying [2 ,9 ]
Ciobanu, Andrea O. [1 ]
Kamath, Deepak Y. [7 ]
Fox, Kathleen A. [2 ]
Rao, Meena P. [2 ]
Pokorney, Sean D. [2 ]
Berwanger, Otavio [4 ,10 ]
Tajer, Carlos [11 ]
de Barros e Silva, Pedro G. M. [4 ,10 ]
Roettig, Mayme L. [2 ]
Huo, Yong [8 ]
Granger, Christopher B. [2 ]
机构
[1] Univ Med & Pharm Carol Davila, Univ & Emergency Hosp, Bucharest, Romania
[2] Duke Univ, Med Ctr, Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA
[3] Univ Fed Sao Paulo, Sao Paulo, Brazil
[4] BCRI, Sao Paulo, Brazil
[5] INECO Neurociencias, Rosario, Santa Fe, Argentina
[6] ACRG, Rosario, Santa Fe, Argentina
[7] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India
[8] Peking Univ, Hosp 1, Beijing, Peoples R China
[9] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27705 USA
[10] Hosp Coracao, Heart Hosp, Res Inst HCor, Sao Paulo, SP, Brazil
[11] Hosp El Cruce, Buenos Aires, DF, Argentina
关键词
ANTITHROMBOTIC TREATMENT; REGIONAL DIFFERENCES; STROKE; THERAPY; PREVENTION; KNOWLEDGE; REGISTRY;
D O I
10.1016/S0140-6736(17)32165-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Oral anticoagulation is underused in patients with atrial fibrillation. We assessed the impact of a multifaceted educational intervention, versus usual care, on oral anticoagulant use in patients with atrial fibrillation. Methods This study was a two-arm, prospective, international, cluster-randomised, controlled trial. Patients were included who had atrial fibrillation and an indication for oral anticoagulation. Clusters were randomised (1:1) to receive a quality improvement educational intervention (intervention group) or usual care (control group). Randomisation was carried out centrally, using the eClinicalOS electronic data capture system. The intervention involved education of providers and patients, with regular monitoring and feedback. The primary outcome was the change in the proportion of patients treated with oral anticoagulants from baseline assessment to evaluation at 1 year. The trial is registered at ClinicalTrials. gov, number NCT02082548. Findings 2281 patients from five countries (Argentina, n=343; Brazil, n=360; China, n=586; India, n=493; and Romania, n=499) were enrolled from 48 clusters between June 11, 2014, and Nov 13, 2016. Follow-up was at a median of 12.0 months (IQR 11.8-12.2). Oral anticoagulant use increased in the intervention group from 68% (804 of 1184 patients) at baseline to 80% (943 of 1184 patients) at 1 year (difference 12%), whereas in the control group it increased from 64% (703 of 1092 patients) at baseline to 67% (732 of 1092 patients) at 1 year (difference 3%). Absolute difference in the change between groups was 9.1% (95% CI 3.8-14.4); odds ratio of change in the use of oral anticoagulation between groups was 3.28 (95% CI 1.67-6.44; adjusted p value=0.0002). Kaplan-Meier estimates showed a reduction in the secondary outcome of stroke in the intervention versus control groups (HR 0.48, 95% CI 0.23-0.99; log-rank p value=0.0434). Interpretation A multifaceted and multilevel educational intervention, aimed to improve use of oral anticoagulation in patients with atrial fibrillation and at risk for stroke, resulted in a significant increase in the proportion of patients treated with oral anticoagulants. Such an intervention has the potential to improve stroke prevention around the world for patients with atrial fibrillation.
引用
收藏
页码:1737 / 1746
页数:10
相关论文
共 30 条
  • [11] The Educational Needs of Clinicians Regarding Anticoagulation Therapy for Prevention of Thromboembolism and Stroke in Patients With Atrial Fibrillation
    Glauser, Terry Ann
    Barnes, Justin
    Nevins, Holder
    Cerenzia, Wendy
    [J]. AMERICAN JOURNAL OF MEDICAL QUALITY, 2016, 31 (01) : 38 - 46
  • [12] Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    Hart, Robert G.
    Pearce, Lesly A.
    Aguilar, Maria I.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) : 857 - 867
  • [13] Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation
    Hendriks, Jeroen M. L.
    de Wit, Rianne
    Crijns, Harry J. G. M.
    Vrijhoef, Hubertus J. M.
    Prins, Martin H.
    Pisters, Ron
    Pison, Laurent A. F. G.
    Blaauw, Yuri
    Tieleman, Robert G.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (21) : 2692 - 2699
  • [14] Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association
    Hernandez Madrid, Antonio
    Potpara, Tatjana S.
    Dagres, Nikolaos
    Chen, Jian
    Larsen, Torben B.
    Estner, Heidi
    Todd, Derick
    Bongiorni, Maria G.
    Sciaraffia, Elena
    Proclemer, Alessandro
    Cheggour, Saida
    Amara, Walid
    Blomstrom-Lundqvist, Carina
    [J]. EUROPACE, 2016, 18 (03): : 463 - 467
  • [15] The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2
    Huisman, Menno V.
    Rothman, Kenneth J.
    Paquette, Miney
    Teutsch, Christine
    Diener, Hans-Christoph
    Dubner, Sergio J.
    Halperin, Jonathan L.
    Ma, Chang Sheng
    Zint, Kristina
    Elsaesser, Amelie
    Bartels, Dorothee B.
    Lip, Gregory Y. H.
    Abban, Dzifa
    Abdul, Nasser
    Abelson, Mark
    Ackermann, Alan
    Adams, Fran
    Adams, Luthando
    Adragao, Pedro
    Ageno, Walter
    Aggarwal, Rajesh
    Agosti, Sergio
    Marin, Javier Aguila
    Aguilar, Francisco
    Linares, Julio Alberto Aguilar
    Aguinaga, Luis
    Ahmad, Zia
    Ainsworth, Paul
    Al Ghalayini, Kamal
    Al Ismail, Saad
    Alasfar, Abdelfatah
    Alawwa, Abdul
    Al-Dallow, Raed
    Alderson, Lisa
    Alexopoulos, Dimitrios
    Ali, Abdullah
    Ali, Malik
    Aliyar, Pareed
    Al-Joundi, Tammam
    Al Mahameed, Soufian
    Almassi, Hossein
    Almuti, Khalid
    Al-Obaidi, Mohamed
    Alshehri, Mohamed
    Altmann, Ute
    Alves, Alvaro Rabelo, Jr.
    Al-Zoebi, Ayham
    Amara, Walid
    Amelot, Mathieu
    Amjadi, Nima
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (07) : 777 - 785
  • [16] Major Hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation
    Hylek, Elaine M.
    Evans-Molina, Carmella
    Shea, Carol
    Henault, Lori E.
    Regan, Susan
    [J]. CIRCULATION, 2007, 115 (21) : 2689 - 2696
  • [17] LONGITUDINAL DATA-ANALYSIS USING GENERALIZED LINEAR-MODELS
    LIANG, KY
    ZEGER, SL
    [J]. BIOMETRIKA, 1986, 73 (01) : 13 - 22
  • [18] Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
    Lip, Gregory Y. H.
    Laroche, Cecile
    Boriani, Giuseppe
    Dan, Gheorghe-Andrei
    Santini, Massimo
    Kalarus, Zbigniew
    Rasmussen, Lars Hvilsted
    Oliveira, Mario Martins
    Mairesse, Georges
    Crijns, Harry J. G. M.
    Simantirakis, Emmanouil
    Atar, Dan
    Maggioni, Aldo P.
    Tavazzi, Luigi
    [J]. EUROPACE, 2015, 17 (02): : 194 - 206
  • [19] Does a complex intervention increase patient knowledge about oral anticoagulation? - a cluster-randomised controlled trial
    Maikranz, Verena
    Siebenhofer, Andrea
    Ulrich, Lisa-R.
    Mergenthal, Karola
    Schulz-Rothe, Sylvia
    Kemperdick, Birgit
    Rauck, Sandra
    Pregartner, Gudrun
    Berghold, Andrea
    Gerlach, Ferdinand M.
    Petersen, Juliana J.
    [J]. BMC FAMILY PRACTICE, 2017, 18
  • [20] Montalescot G., 2016, CIRCULATION, V134